Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Avantor Inc. (AVTR)

NYSE: AVTR · Laboratory Analytical Instruments · Radnor, PA

Our rating: Neutral

Neutral reaffirmed at $15.61, moderate conviction, November 2, 2026.

Breaks if: The Neutral call turns Cautious if the revenue decline steepens to -6% or worse in either of the next two quarterly filings, or if trailing free cash flow falls below $350M — either would suggest the end-market pressure is worse than today's figures reflect. It turns Positive if revenue returns to at least 2% growth for two consecutive quarters while free cash flow holds at or above $450M, signaling the destocking cycle has genuinely cleared and the cash-conversion profile is durable at a recovering top line.

Key figures

Market value$10.1B
Revenue, last 12 months$6.6B
Net income, last 12 months$337M
Free cash flow, last 12 months$439M
Price to earnings29.8×
Free cash flow yield4.4%
Dividend yield0.0%
Operating margin7.3%
Return on equity5.9%
Beta to the S&P 5000.94
Volatility, annualized46.3%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$1.7B4.6%$0.30$156M
June 30, 2026$1.7B0.5%$0.06$141M
March 31, 2026$1.6B0.0%$0.06$25M
December 31, 2025$1.7B−1.4%$0.08$117M
September 30, 2025$1.6B−5.3%$-1.04$172M
June 30, 2025$1.7B−1.1%$0.09$125M
March 31, 2025$1.6B−5.9%$0.09$81M
December 31, 2024$1.7B−2.1%$0.73$146M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

13 ledger entries and 61 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.